April 26, 2021 CARISMA Therapeutics Establishes Collaboration with Leading Cell Therapy Expert to Explore and Develop Allogeneic CAR-Macrophages
April 16, 2021 Oncopeptides submits application for conditional marketing authorization of melflufen in the EU